- Home
- CYCC vs QNRX Comparison
CYCC vs QNRX Comparison
Compare CYCC & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- QNRX
- Stock Information
- Founded
- CYCC 1992
- QNRX 2018
- Country
- CYCC United States
- QNRX United States
- Employees
- CYCC N/A
- QNRX N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- QNRX Medical/Dental Instruments
- Sector
- CYCC Health Care
- QNRX Health Care
- Exchange
- CYCC Nasdaq
- QNRX Nasdaq
- Market Cap
- CYCC 1.8M
- QNRX 2.1M
- IPO Year
- CYCC N/A
- QNRX N/A
- Fundamental
- Price
- CYCC $0.37
- QNRX $0.64
- Analyst Decision
- CYCC Buy
- QNRX Strong Buy
- Analyst Count
- CYCC 2
- QNRX 1
- Target Price
- CYCC $11.00
- QNRX $4.00
- AVG Volume (30 Days)
- CYCC 3.7M
- QNRX 486.4K
- Earning Date
- CYCC 11-12-2024
- QNRX 11-07-2024
- Dividend Yield
- CYCC N/A
- QNRX N/A
- EPS Growth
- CYCC N/A
- QNRX N/A
- EPS
- CYCC N/A
- QNRX N/A
- Revenue
- CYCC $74,000.00
- QNRX N/A
- Revenue This Year
- CYCC N/A
- QNRX N/A
- Revenue Next Year
- CYCC $16.28
- QNRX N/A
- P/E Ratio
- CYCC N/A
- QNRX N/A
- Revenue Growth
- CYCC N/A
- QNRX N/A
- 52 Week Low
- CYCC $0.35
- QNRX $0.48
- 52 Week High
- CYCC $6.00
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- CYCC 29.98
- QNRX 43.06
- Support Level
- CYCC $0.35
- QNRX $0.57
- Resistance Level
- CYCC $0.52
- QNRX $0.64
- Average True Range (ATR)
- CYCC 0.07
- QNRX 0.06
- MACD
- CYCC -0.01
- QNRX -0.02
- Stochastic Oscillator
- CYCC 3.94
- QNRX 14.06
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.